ISSN: 0443-511
e-ISSN: 2448-5667
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Manifestaciones oculares asociadas a CD4+ en pacientes con virus de inmunodeficiencia humana / Ocular manifestations associated to CD4+ in patients with human immunodeficiency virus

Ana María Ponce-Horta, Evelia Ana Florencia Ponce-Horta, Daniel Valencia-Paredes, Mario Salvador García-Contreras, Nancy Paola Arias-González



Introducción: desde los primeros casos de virus de inmunodeficiencia humana (VIH), se conocen manifestaciones oculares secundarias a la infección y estas se han relacionado con el conteo de linfocitos CD4+.

Objetivo: describir la correlación entre las manifestaciones oculares en pacientes con VIH y el conteo de linfocitos CD4+.

Material y métodos: estudio transversal analítico de pacientes con VIH, en quienes se analizó la correlación entre conteo de CD4+ y manifestaciones oftalmológicas.

Resultados: se incluyeron 21 pacientes entre 26 y 67 años de edad. Solo tres no se encontraban en terapia antirretroviral. El 67% presentó algún tipo de manifestación ocular, 42% presentó manifestaciones no relacionadas con la infección, 47% manifestaciones relacionadas y 24% ambas. La microangiopatía de la conjuntiva fue la manifestación ocular más frecuente (35.7%). Hubo una correlación estadísticamente significativa (r = 0.76, p = 0.0001) entre las manifestaciones oculares relacionadas con la infección y el conteo de linfocitos CD4+.

Conclusiones: los pacientes con VIH presentan con frecuencia manifestaciones oculares, la mayoría asociadas a la infección. Existe correlación entre la presencia de estas con el conteo de CD4+; sin embargo, un número similar de manifestaciones no asociadas a la infección se presentaron sin correlación con el conteo, por lo que los pacientes con VIH deberían tener revisiones oftalmológicas periódicas, independientemente del conteo de CD4+.



Background: Since the first cases of human immunodeficiency virus (HIV), ocular manifestations secondary to infection have been known and these have been related to the CD4+ lymphocyte count.

Objective: To describe the correlation between ocular manifestations in patients with HIV and the CD4+ lymphocyte count.

Material and methods: Analytical cross-sectional study of patients with HIV whose CD4+ count was correlated with the presence of ophthalmological manifestations.

Results: 21 patients between 26 and 67 years were studied. Only 3 patients were not on antiretroviral therapy. 67% of the patients presented some type of ocular manifestation, 42% presented non-infection related manifestations, 47% related manifestations and 24% both. Conjunctival microangiopathy was the most frequent ocular manifestation (35.7%). There was a statistically significant correlation (r = 0.76, p = 0.0001) between eye manifestations related to infection and CD4+ lymphocyte count.

Conclusions: Patients with HIV frequently present ocular manifestations, the majority related to infection; there is a correlation between the presence of these with the CD4+ count. However, a similar number of manifestations not related to infection occurred without correlation with the count; therefore, HIV patients should have periodic ophthalmological examinations, independently of CD4+ count.


Palabras clave

VIH; SIDA; Manifestaciones Oculares; Linfocitos T CD4-Positivos / HIV; AIDS; Eye Manifestations; CD4 Lymphocyte Count

Texto completo:




Centers for Disease Control. Epidemiological aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med. 1982;306:248-52. doi: 10.1056/NEJM198201283060431.


Feroze KB, Wang J. Ocular Manifestations of HIV. StatPearls [Internet]; 2019.


Holland GN, Gottlieb MS, Yee RD, Schanker HM, Pettit TH. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol. 1982;93:393-402. doi: 10.1016/0002-9394(82)90127-1.


Holland GN, Pepose JS, Pettit TH. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983;90:859-73. doi: 10.1016/s0161-6420(83)80009-8.


Secretaría de Salud, Centro Nacional para la Prevención y el Control de VIH y el SIDA, Dirección General de Epidemiología. Vigilancia Epidemiológica de casos de VIH/SIDA en México. Registro Nacional de Casos de SIDA. Actualización al Cierre de 2019. México: Secretaría de Salud; 2019. Disponible en


German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’. Human Immunodeficiency Virus (HIV). Transfus Med Hemother. 2016;43(3):203-22. doi:10.1159/000445852.


Kasper DL, Harrison TR. Principios de medicina interna. 19a. ed. México: McGraw-Hill; 2016.


Sharma M, Chauhan A, Sharma G, Chauhan V. Ocular manifestations in patients attending antiretroviral therapy centre at a tertiary care hospital in Himachal Pradesh, India. Indian J Med Res. 2018;147(5):496-500. doi:10.4103/ijmr.IJMR_1037_15.


Hodge WG, Seiff SR, Margolis TP. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology. 1998;105(5):895-900. doi: 10.1016/S0161-6420(98)95033-3.


Biswas J, Sudharshan S. Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol. 2008;56:363-75. doi: 10.4103/0301-4738.42412.


Yeak J, Iqbal T, Zahari M, Ismail F. Total resolution of ocular Kaposi sarcoma with different treatment approaches – a case series and review of literature. Int J STD AIDS. 2019;30(8):802-9. doi: 10.1177/0956462418825353.10.


Britto GR, Augustine M. Mucocutaneous manifestations of human immunodeficiency virus (HIV) infection in children in relation to the degree of immunosuppression. Int J Dermatol. 2019;58(10):1165-71. doi: 10.1111/ijd.14440.


Ali R, Kim JY, Henderson BA. Adnexal and anterior segment manifestations of HIV/AIDS. Int Ophthalmol Clin. 2007;47(2):15-32. doi: 10.1097/IIO.0b013e318036bcc4.


Hodge WG, Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: An epidemiologic study. Ophthalmology. 1997;104:120-4. doi: 10.1016/s0161-6420(97)30351-0.


Kim YS, Sun HJ, Kim TH, Kang KD, Lee SJ. Ocular Manifestations of Acquired Immunodeficiency Syndrome. Korean Journal of Ophthalmology. 2015;29(4):241. doi: 10.3341/kjo.2015.29.4.241.


Koripalli S, Rueda L, Gummadi PP. A Rare Case of Neurosyphilis with Ocular Involvement in a Patient with HIV Infection and New Onset Syphilis. Cureus. 2019; 11(2):4034. doi: 10.7759/cureus.4034.


Engstrom RE, Jr., Holland GN, Margolis TP. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994;101(9): 1488-502. doi: 10.1016/s0161-6420(94)31142-0.


Cunningham ET, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339(4):236-44. doi: 10.1056/NEJM199807233390406.


Port AD, Orlin A, Kiss S, Patel S, Damico DJ, Gupta MP. Cytomegalovirus Retinitis: A Review. Journal of Ocular Pharmacology and Therapeutics. 2017;33(4):224-34. doi: 10.1089/jop.2016.0140.


Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985; 62(4): 475-95. doi: 10.3171/jns.1985.62.4.0475.


Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986; 45(6): 635-46. doi: 10.1097/00005072-198611000-00003.


Wadood AC, Dhillon B, Mcilwaine G, Brettle RP. Delayed diagnosis of HIV infection in ophthalmic practice. Eye. 2004;18(3):293-8. doi: 10.1038/sj.eye.6700630.


Holkar S, Mudhar HS, Jain A, Gupta M, Rogstad KE, Parsons MA. Regression of invasive conjunctival Squamous carcinoma in an HIV-positive patient on antiretroviral therapy. Int J STD AIDS. 2005;16:782-3. doi: 10.1038/bjc.2013.539.


Baldassano VF, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995;333:670. doi: 10.1056/NEJM199509073331019.


Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(1):231-3. doi: 10.1086/313612.


Sorenson RB, Leng BH. Ophthalmic Manifestations of Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy. Arch Ophthalmol. 2012;130(12):1621-3.


Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Disponible en


Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(1):1-34. doi: 10.1093/cid/cit665.


Nishijima T, Yashiro S, Teruya K, Kikuchi Y, Katai N, Oka S, et al. Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL. PLoS One. 2015;110(9). doi: 10.1371/journal.pone.0136747.


Enlaces refback

  • No hay ningún enlace refback.